Mixture, aqueous solution comprising mixture and use of aqueous solution
By designing the temperature-dependent assembly mechanism of complementary bases in polymers, the problems of inaccurate release and insufficient loading of thermally responsive active substance delivery system in the prior art are solved, and the body temperature is 37°C. The release of active substances in the narrow temperature range above and the high loading volume reduces the risk of thermal damage to healthy tissues.
Patent Information
- Application Number
- CN202380024748.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-01
- Filing Date
- 2023-02-24
- Publication Date
- 2024-11-26
AI Technical Summary
The existing thermally responsive active substance delivery systems are difficult to achieve precise temperature-dependent release in organisms with a body temperature of 37°C, and the existing UCST polymer and DNA-based systems have insufficient release temperature range and loading capacity.
Using a first and a second polymer containing at least six bases, which is assembled into micelles or vesicles by forming hydrogen bonds at ≤37°C, dissociating at >37°C, achieving narrowing of the active substance Release within the temperature range.
Release of active substances within a narrow temperature range above 37°C is achieved, allowing higher loading and simple and economical industrial-scale production, reducing the risk of thermal damage to healthy tissues.
Smart Images

Figure CN119032133A_ABST
Abstract
Description
[0001] A mixture comprising a first polymer and a second polymer is provided. The first polymer and the second polymer each comprise at least six bases, each of which is covalently bound to a monomer of the respective polymer. The at least six bases of the second polymer are complementary to the at least six bases of the first polymer. At a temperature of ≤37°C, the two polymers can be assembled into micelles or vesicles (preferably vesicles) through their complementary bases, but will not be assembled into micelles or vesicles at a temperature of>37°C. According to the present invention, an aqueous solution comprising the mixture according to the present invention is also provided, and the use of the aqueous solution is proposed.
[0002] The temperature-controlled release of substances can play an important role in many areas of application. These range from medical applications (e.g. tumor therapy) and cosmetic applications to technological processes for the release of coolants or lubricants.
[0003] Stimuli-responsive active substance delivery systems are designed to help release their active substances in a spatially, temporally, and dose-controlled manner. The control of release can be endogenous, i.e. triggered by conditions at the target site (e.g. pH, enzyme concentration, redox gradient), or exogenous, i.e. triggered by external stimuli (e.g. temperature changes, magnetic fields, ultrasound, light treatment).
[0004] Thermoresponsive systems are generally based on a temperature-dependent, preferably abrupt, non-linear change in the physicochemical properties of at least one component of the carrier material, which leads to the release of the active substance encapsulated therein.
[0005] Polymer-based transporters of thermoresponsive active substances based on so-called UCST polymers (Upper Critical Solution Temperature polymers) are known in the prior art. In principle, oxazolines can be used to transport active substances, but since their transition temperature (release temperature) is already 30°C, they are not suitable for targeted release of active substances in living organisms with a body temperature of 37°C (Hoogenboom, R. et al., Soft Matter, 2009, vol. 5. p. 3590-3592). It is known that the UCST polymer poly (AAm-co-AN) -g-PEG forms vesicles in aqueous solution that can be loaded with the active substance doxorubicin. However, these vesicles show temperature-dependent release of doxorubicin in a very wide temperature range of 4°C to 43°C, which also makes them unsuitable for targeted release of active substances in organisms with a body temperature of 37°C (Li, WS et al., Angew. Chem. Int. ed., 2015, vol. 54, p. 3126-3131).
[0006] For known UCST polymer systems, it is currently impossible to precisely set the transition threshold that changes sharply to achieve safe and sensitive release behavior under in vivo conditions.
[0007] Ideally, the transition temperature of a thermoresponsive system as a carrier of an active substance should be very close to the physiological body temperature of 37°C, so that in healthy tissue, i.e., already at 37°C, no non-specific release occurs. On the other hand, however, even a small increase in the local temperature of only a few Kelvin (e.g. to about 40°C to 42°C) should ideally be sufficient to induce the release of the active substance, since if the necessary transition temperature is too high, very high heating of the body tissue would be required, which could also damage certain healthy tissues in the body (e.g., tissue near a tumor) in the desired manner.
[0008] In the prior art, a DNA-based active substance delivery system is known, in which mesoporous silica particles are covalently bound to single-stranded DNA, and the single-stranded DNA is hybridized with complementary single-stranded DNA covalently bound to iron oxide nanoparticles, thereby sealing the pores of the mesoporous silica particles (Ruiz-Hernandez, E. et al., ACS Nano, 2011, vol. 5, p. 1259-1266). The DNA hybridization is unzipped by increasing the temperature, and then the pores of the mesoporous silica particles are allowed to open and release the active substances encapsulated therein. However, this DNA-based active substance release system is complex to manufacture, only allows a relatively low active substance loading compared to the total weight of the system, and has a relatively wide active substance release temperature range.
[0009] Based on this, the object of the present invention is to provide an active substance release system (or mixture) which does not have the disadvantages of the prior art. In particular, the active substance system should be simple and economical to produce on an industrial scale, allow a relatively high active substance loading compared to the total weight of the system, and release the active substance in a temperature range that is as narrow as possible >37°C.
[0010] This object is achieved by a mixture having the features of claim 1, an aqueous solution having the features of claim 12 and a use having the features of claim 15. The dependent claims describe advantageous developments.
[0011] According to the present invention there is provided a mixture comprising
[0012] a) a first polymer comprising at least six bases, each of which is covalently bonded to a monomer of the polymer; and
[0013] b) a second polymer comprising at least six bases, each of which is covalently bound to a monomer of the polymer, wherein the at least six bases of the second polymer are complementary to the at least six bases of the first polymer;
[0014] The invention is characterized in that the first polymer and the second polymer can react in aqueous solution through their complementary bases.
[0015] At a temperature of ≤37°C, they assemble into micelles or vesicles (i.e., form micelles or vesicles or exist in the form of micelles or vesicles) by forming hydrogen bonds between their complementary bases, and
[0016] At temperatures > 37°C, they do not assemble into micelles or vesicles (ie, do not form micelles or vesicles or do not exist in the form of micelles or vesicles) due to the lack of hydrogen bonds between their complementary bases.
[0017] The self-assembly of the polymer components in the mixture at temperatures ≤37°C is based on the formation of hydrogen bonds between the individual complementary bases of the two polymers, which leads to the formation of micelles or vesicles by the two polymers. If the melting temperature of the bonds between the complementary bases is exceeded at temperatures >37°C, the bonds between the two polymers disappear, i.e. the two polymers dissociate and enter a non-micelle or non-vesicle state. The micelles or vesicles dissolve in the process. If the active substance is encapsulated in the micelles or vesicles, it is released. If the temperature range for the melting of hydrogen bonds is very narrow, i.e. only a few Kelvin, then a temperature difference of a few Kelvin above 37°C (e.g. a temperature jump from 37°C to 40°C) can already lead to the release of the active substance.
[0018] The mixture according to the invention has the advantage that the active substance can be released in a temperature range of >37°C, in particular in a narrower temperature range above 37°C (e.g. 1K to 5K above 37°C, preferably 1K to 3K above 37°C). In addition, the mixture can be produced simply and economically on an industrial scale. In addition, if the first polymer and the second polymer form vesicles as active substance carriers, the mixture allows a relatively high active substance loading. The vesicles provide a large internal space for loading the active substance, and the polymers forming the vesicles are very small in volume relative to this large internal space and are therefore light in weight. Therefore, preferably, the first polymer and the second polymer form vesicles. If the first polymer and the second polymer form micelles, it is also possible to achieve a certain degree of active substance loading, but relatively small (especially for more hydrophobic active substances).
[0019] This property makes the mixture according to the invention particularly useful for thermoinduced transformations in living organisms with a body temperature of 37° C., since in this case the mixture according to the invention is particularly advantageous if the temperature required for the transformation is not much higher than 37° C. (reason: less undesired thermal damage to the tissue can occur). For example, it is known that the temperature of a cancerous tumor in vivo can be 1 K to 2 K higher than the temperature of the surrounding body tissue (which is 37° C.), which means that the mixture according to the invention can be used to release active substances in vivo, especially at the tumor site.
[0020] The formation of vesicles is preferred because vesicles provide a larger internal space for loading active substances, thereby allowing the loading of larger active substance molecules or a larger number of smaller active substance molecules. Therefore, preferably, the first polymer and the second polymer can be assembled into vesicles (i.e., form vesicles or exist in the form of vesicles) through their complementary bases in aqueous solution at a temperature of ≤37°C by forming hydrogen bonds between their complementary bases; and, at a temperature of >37°C, due to the lack of hydrogen bonds between their complementary bases, they do not assemble into vesicles (i.e., do not form vesicles or do not exist in the form of vesicles).
[0021] In a preferred embodiment, the mixture comprises a magnesium salt (such as MgCl2) and / or a magnesium complex, particularly preferably in a concentration of 10 mM to 30 mM. If the first polymer and / or the second polymer comprises at least one monomer comprising a phosphate residue (such as a ribose-5-phosphate residue), the presence of magnesium may be advantageous for the formation of vesicles or micelles.
[0022] In a preferred embodiment, the mixture contains an active substance, wherein the active substance is preferably selected from the group consisting of pharmaceutical active substances, cosmetic substances, sensor substances, lubricants, coolants, adhesives and combinations thereof. The active substance is particularly preferably selected from the group consisting of pharmaceutical active substances, fragrances, antiperspirants, UV protectants, coolants, lubricants, adhesives and combinations thereof. In this case, the advantage is that the two polymers of the mixture according to the invention form micelles or vesicles in aqueous solution at a temperature of ≤37° C., and the active substance can be encapsulated in the interior of the micelles or vesicles.
[0023] In other optional embodiments, the first polymer and / or the second polymer are linear (i.e. non-branched) polymers. Alternatively, the first polymer and / or the second polymer are nonlinear (i.e. branched) polymers. In this case, the first polymer and / or the second polymer can have at least one side chain, optionally two side chains. If the first polymer and / or the second polymer have one or two side chains, it can be a modified 3-arm PEG or a modified 4-arm PEG (e.g., average molar mass is 1000 g / mol to 6000 g / mol, preferably 2000 g / mol to 5000 g / mol), and the PEG has monomers on at least two arms, preferably monomers on at least three arms (optionally, for 4-arm PEG, monomers on four arms). Wherein, each monomer is covalently bound to a base respectively (preferably, at one end of each arm). The key factor is that 3-arm PEG or 4-arm PEG has at least six bases, and each base is covalently bound to a monomer of the polymer respectively. For example, at least four or six such monomers may be present on one arm of a 3-arm PEG or a 4-arm PEG, and four or six such monomers may also be present on the second arm of the PEG. The other arms of a 3-arm PEG or a 4-arm PEG may have no such monomers, i.e., only monomers that do not bind to a base (abasic monomers).
[0024] The first polymer may contain or consist of at least 20 monomers, preferably at least 50 monomers, particularly preferably at least 100 monomers, very particularly preferably at least 200 monomers, in particular at least 500 monomers. In addition, the second polymer may contain or consist of at least 20 monomers, preferably at least 50 monomers, particularly preferably at least 100 monomers, very particularly preferably at least 200 monomers, in particular at least 500 monomers. The first polymer and / or the second polymer may contain up to 600 monomers, optionally up to 500 monomers.
[0025] The first polymer may contain at least ten bases, preferably at least twelve bases, particularly preferably at least 14 bases, in particular at least 16 bases, optionally up to 18 bases, each of which is covalently bound to a monomer of the first polymer. The second polymer may contain at least ten bases, preferably at least twelve bases, particularly preferably at least 14 bases, in particular at least 16 bases, optionally up to 18 bases, each of which is covalently bound to a monomer of the second polymer, wherein the bases of the second polymer are complementary to the bases of the first polymer. The more complementary bases the first polymer and the second polymer contain, the higher the melting temperature of the hybridized bases, i.e. the temperature at which micelles and / or vesicles dissociate at >37°C is higher than 37°C.
[0026] The first polymer may have a maximum of 16 bases, preferably a maximum of 14 bases, particularly preferably a maximum of 12 bases, optionally a maximum of 10 bases. In addition, the second polymer may have a maximum of 16 bases, preferably a maximum of 14 bases, particularly preferably a maximum of 12 bases, optionally a maximum of 10 bases. The fewer mutually complementary bases the first polymer and the second polymer contain, the lower the melting temperature of the hybridized bases, i.e. the temperature at which micelles and / or vesicles dissociate at >37°C is closer to 37°C.
[0027] In the first polymer, between two consecutive monomers that are each respectively bound to a base, up to three monomers that are not covalently bound to the base in each case can be arranged, preferably up to two monomers, particularly preferably up to one monomer, and in particular, monomers that are not covalently bound to the base in each case are not arranged, i.e., the base is not bound to the abasic monomer in each case. The term "abasic monomer" refers to a monomer that is not bound to the base by itself (i.e., regarded as a separate synthetic building block in the polymer). In other words, the abasic monomer is only (indirectly) bound to the base through adjacent monomers in the polymer (which can be regarded as "spacers"). In addition, in the second polymer, between two consecutive monomers that are each respectively bound to a base, up to three monomers that are not covalently bound to the base in each case can be arranged, preferably up to two monomers, particularly preferably up to one monomer, and in particular, monomers that are not covalently bound to the base in each case are not arranged, i.e., the base is not bound to the abasic monomer in each case. If no abasic monomer is arranged between two consecutive monomers that are bound to the base, the base is bound to the continuous monomers in the polymer. The advantage of such an arrangement of bases along the polymer chain is that a reversible binding mechanism is created over the shortest possible length, which can reversibly bind the first polymer to the second polymer (T≤37°C) or separate them from each other (T>37°C) depending on the ambient temperature.
[0028] The first polymer and / or the second polymer may comprise at least one monomer or oligomer (preferably at least one monomer, particularly preferably exactly one monomer), which is not covalently bound to a base in each case (i.e. it is an abasic monomer) and is covalently bound to at least one additional polymer (optionally, two additional polymers, for example in 3-PEG or 4-PEG). Preferably, the additional polymer is suitable for causing phase separation after assembly of the first polymer and the second polymer in an aqueous medium. The additional polymer may comprise polyethylene glycol or consist of polyethylene glycol.
[0029] The base of the first polymer can be a base comprising or consisting of cytosine, isocytosine and / or adenine, preferably cytosine. In addition, the base of the second polymer is a base comprising or consisting of guanine, isocytosine and / or thymine, preferably guanine. The combination of cytosine or isocytosine (the first polymer) and guanine or isoguanine (the second polymer) is preferred, because the cytosine-guanine bond (or isocytosine-isoguanine bond) is established by three hydrogen bonds, which is stronger than the adenine-thymine bond established by only two hydrogen bonds. Therefore, the advantage of using cytosine, guanine, isocytosine and isoguanine is that the number of bases required for setting a certain (de)assembly temperature is less than when using adenine and thymine. Therefore, this reversible binding mechanism can be established on a shorter length along the first polymer and the second polymer.
[0030] The base of the first polymer can be bound to the monomer of the first polymer through a ribose residue, wherein the base is preferably bound to the C1 atom of the ribose residue, and the monomer is bound to the C5 atom of the ribose residue. In addition, each base of the second polymer can be bound to a monomer of the first polymer through a ribose residue, wherein the base is preferably bound to the C1 atom of the ribose residue, and the monomer is bound to the C5 atom of the ribose residue. The advantage of binding through a ribose residue is that the ribose residue is relatively hydrophilic, and thus the water solubility of the first polymer and / or the second polymer can be improved.
[0031] The monomers in the first polymer and / or the second polymer, each of which is bound to a base, can each contain or consist of a residue selected from an amino acid residue, a sugar residue, a ribose phosphorylation residue, a methacrylamide residue, and a combination thereof. The residue is preferably selected from a ribose phosphorylation residue, a methacrylamide residue, and a combination thereof, and is particularly preferably selected from a ribose-5-phosphate residue, an N-(3-aminopropyl)-methacrylamide residue, and a combination thereof. The advantage of the ribose-5-phosphate residue and the N-(3-aminopropyl)-methacrylamide residue is that they are relatively hydrophilic and can therefore improve the water solubility of the first polymer and / or the second polymer.
[0032] In addition, the monomers in the first polymer and / or the second polymer, each of which is bound to a base, can form homopolymers. The homopolymer is preferably selected from polypeptides, polysaccharides, polyribose phosphates, polymethacrylamide and combinations thereof. Particularly preferably, the homopolymer is selected from poly-ribose phosphates, polymethacrylamide and combinations thereof. In particular, the homopolymer is selected from poly-ribose-5-phosphate, poly-(N-(3-aminopropyl)-methacrylamide and combinations thereof. The advantage is that these homopolymers are relatively hydrophilic and can therefore improve the water solubility of the first polymer and / or the second polymer.
[0033] In addition, the monomers in the first polymer and / or the second polymer, each of which is bound to a base, can be covalently bound to the base through a bond selected from an ester bond, a thioester bond, an ether bond and an amide bond (optionally through a ribose residue). Preferably, the bond is an amide bond, particularly preferably an amide bond bound to a ribose residue covalently bound to the base. In particular, the bond is an amide bond bound to the C5 atom of the ribose residue, and the ribose residue is also covalently bound to the base on its C1 atom. The amide bond has an advantage because it is a relatively stable bond in an aqueous environment.
[0034] In addition, preferably, the bases covalently bonded to one monomer of each polymer contained in the first polymer and the second polymer are located at the first end of the polymer, the first end of the polymer and the second end of the polymer, or in the middle of the polymer. In other words, the bases along the polymer chain only appear in that specific part (or region or block) of the polymer, and do not appear in other parts (or regions or blocks) outside that part (or region or block) of the polymer.
[0035] For example, if the base is arranged at the first end of the polymer, then each monomer at the second end of the polymer will not have a base connected, that is, only abasic monomers are present at the second end. For example, if the base is arranged at the first end of the polymer and the second end of the polymer, then each monomer in the middle of the polymer will not have a bound base, that is, only abasic monomers are present in the middle. For example, if the base is arranged in the middle of the polymer, then each monomer at the start and end of the polymer (that is, in both directions away from the middle of the polymer) will not have a base connected, that is, only abasic monomers are present in these parts. Therefore, different parts (regions or blocks) of the polymer can have different physical and / or chemical properties. For example, the part in which each monomer in the first polymer and / or the second polymer is not bound to the base (the part with abasic monomers) exhibits a higher degree of freedom at a temperature of ≤37°C because these regions do not participate in the hybridization of the two polymers, that is, these parts will not be "immobilized" due to hybridization. The longer this part with abasic monomers of the first polymer and / or the second polymer is, the more strongly it determines the chemical and physical properties of the micelles or vesicles assembled by the two polymers.
[0036] The monomers (abasic monomers) of the first polymer and / or the second polymer that do not bind to a base may each contain or consist of a residue selected from (N-(2-hydroxypropyl)methacrylamide residues, vinylamine residues, butadiene residues, ethylene oxide residues, acrylic acid residues, amino acid residues (such as glutamic acid residues and / or lysine residues), sugar residues and combinations thereof. Preferably, these monomers contain or consist of (N-(2-hydroxypropyl)methacrylamide residues and / or ethylene oxide residues because these monomers have good water solubility and can therefore provide good water solubility of the first polymer and / or the second polymer.
[0037] The monomers (basic monomers) of the first polymer and / or the second polymer that do not bind to a base can form a homopolymer, and the homopolymer is preferably selected from poly-(N-(2-hydroxypropyl)methacrylamide, polyvinylamine, polyethylene oxide, polypeptides (such as polyglutamic acid and / or polylysine), polysaccharides and combinations thereof, and poly-(N-(2-hydroxypropyl)methacrylamide is particularly preferred. The formation of poly-(N-(2-hydroxypropyl)methacrylamide (pHPMA) and / or polyethylene oxide has advantages because they have good water solubility and can therefore The first polymer and / or the second polymer can provide good water solubility. In addition, the monomers (basic monomers) that are not combined with bases of the first polymer and / or the second polymer can form block copolymers, and the block copolymers are preferably selected from polybutadiene-polyethylene oxide, polyethyleneamine-polyethylene oxide, polyglutamic acid-polyethylene oxide, polyacrylic acid and combinations thereof. In addition, the monomers (basic monomers) that are not combined with bases of the first polymer and / or the second polymer can form heteropolymers, and the heteropolymers are preferably selected from polypeptides, polysaccharides and combinations thereof.
[0038] In a preferred embodiment, the mixture does not contain an organic solvent. Therefore, the mixture can be provided in a manner with lower safety risks, lower costs and more environmentally friendly than mixtures known in the prior art that use organic solvents. It can also encapsulate active substances that may be damaged or even completely destroyed by organic solvents (e.g., certain macromolecular biotherapeutics, such as certain proteins).
[0039] The mixtures according to the invention are also provided for use in medicine, preferably for the thermal release of active substances, particularly preferably for the thermal release of active substances for the treatment of cancer.
[0040] According to the invention, there is also provided an aqueous solution comprising a mixture according to the invention, wherein the first polymer and the second polymer are at least partially (preferably completely) assembled into micelles or vesicles. According to the invention, the term "solution" is also understood as emulsions and suspensions, since micelles and / or vesicles can also be emulsified and / or suspended in the water of the solution.
[0041] The aqueous solution can be obtained, for example, by the following steps: adding water at room temperature (25° C.) to the mixture according to the present invention, incubating the obtained mixture at a temperature higher than 37° C. (such as 40° C. to 100° C.) for a certain time (such as 10 minutes to 100 minutes), and then cooling to a temperature of ≤37° C. Alternatively, water at a temperature higher than 37° C. (such as 40° C. to 100° C.) can be added to the mixture according to the present invention, incubated for a certain time (such as 10 minutes to 100 minutes), and then cooled to a temperature of ≤37° C.
[0042] In a preferred embodiment, the aqueous solution does not contain an organic solvent. The advantage is that the aqueous solution is more compatible physiologically and does not cause damage due to organic solvents when the aqueous solution is administered to a living body.
[0043] The average hydrodynamic radius of the micelles and / or vesicles of the aqueous solution determined by dynamic light scattering may range from 30 nm to 300 nm, preferably from 50 nm to 200 nm, and optionally from 100 nm to 150 nm. The hydrodynamic radius within this range has been shown to be beneficial for the encapsulation and transport of active substances.
[0044] The micelles and / or vesicles of the aqueous solution may contain active substances in the inner space (of the micelles and / or vesicles), wherein the active substances are preferably selected from pharmaceutical active substances, cosmetic substances, sensor substances, lubricants, coolants, adhesives and combinations thereof, and wherein the active substances are particularly preferably selected from pharmaceutical active substances, fragrances, antiperspirants, UV protective substances, coolants, lubricants, adhesives and combinations thereof.
[0045] According to the invention, it is also proposed to use the aqueous solution according to the invention for the thermal release of active substances, preferably for the release of active substances selected from the group consisting of pharmaceutical active substances, cosmetic substances, sensor substances, lubricants, coolants, adhesives and combinations thereof, wherein the active substances are particularly preferably selected from the group consisting of pharmaceutical active substances, fragrances, antiperspirants, UV protection substances, coolants, lubricants, adhesives and combinations thereof.
[0046] The subject matter according to the invention will be explained in more detail on the basis of the following figures and examples, without wishing to restrict these to the specific embodiments presented here.
[0047] Figure 1 Schematically illustrated is the polymerization and self-assembly (self-organization) of a linear first polymer and a second polymer formed from complementary nucleoside block copolymers (C and G), which may comprise a mixture according to the invention.
[0048] Figure 2A shows the synthesis of base (NB) monomer derivatives in the form of a reaction scheme: (i) TEMPO, BAIB, CH3CN / H2O, room temperature, overnight (3:44%, 4:98%); (ii) APMA*HCl, CDMT, NMM, MeOH, room temperature, overnight (1:44%, 2:52%).
[0049] Figure 2 B shows the chemical structure of ribonucleoside methacrylamide, specifically cytidine methacrylamide derivative (1) and guanosine methacrylamide derivative (2), which can be polymerized to produce one end of a first polymer (e.g., polymerization of cytidine methacrylamide derivative) and one end of a second polymer (e.g., polymerization of guanosine methacrylamide derivative), wherein the first end comprises monomers each covalently bonded to a base (= the base-containing region of the first polymer and / or the second polymer).
[0050] Figure 2 C shows the synthesis of pHPMA 9 and nucleoside-based block copolymers pHPMA-b-piCPMA 11 and pHPMA-b-piGPMA 12 in the form of a reaction scheme: (i) ACVA, acetic acid buffer (pH 5) / EtOH, 70°C, 24 hours; (ii) ACVA, DMF / H2O or 1,4-dioxane / H2O, 75°C, 24 hours. pHPMA can represent the second end of the first polymer and the second end of the second polymer, wherein the second end in each case comprises a monomer that is not covalently bound to a base (=abasic region of the first polymer and the second polymer). The nucleoside-based block copolymer pHPMA-b-piCPMA 11 can represent the first polymer of the mixture according to the present invention, while the nucleoside-based block copolymer pHPMA-b-piGPMA 12 can represent the second polymer of the mixture according to the present invention.
[0051] Figure 2 D shows the acidic deprotection of the acetonide functional group of pHPMA-b-piCPMA 11 and pHPMA-b-piGPMA 12 in the form of a reaction scheme: (i) TFA, H2O, room temperature, 2 hours (11: 53%, 12: 81%) to establish OH groups on the C2 and C3 atoms of the ribose residue. This measure can improve the solubility of pHPMA-b-piCPMA 11 and pHPMA-b-piGPMA 12 in water.
[0052] Figure 3Analytical data of piCPMA 5 and piGPMA 6, i.e., a portion (e.g., piCPMA 5) of a first polymer (e.g., pHPMA-b-piCPMA) and a portion (e.g., piGPMA 6) of a second polymer (e.g., pHPMA-b-piGPMA) of a mixture according to the present invention, are shown.
[0053] Figure 4 Analytical data of pHPMA-b-piCPMA 11 and pHPMA-b-piGPMA 12, ie, the first polymer (eg, pHPMA-b-piCPMA) and the second polymer (eg, pHPMA-b-piGPMA) of a mixture according to the present invention are shown.
[0054] Figure 5 A shows the SEM image, particle size distribution, and hydrodynamic particle size distribution of pHPMA-b-pCPMA 13 determined by DLS.
[0055] Figure 5 B shows the SEM image, particle size distribution, and hydrodynamic particle size distribution of pHPMA-b-pGPMA 14 determined by DLS.
[0056] Figure 6 A shows the SEM image, particle size distribution, and hydrodynamic particle size distribution determined by DLS of a mixture of pHPMA-b-pCPMA 13 and pHPMA-b-pGPMA 14 at room temperature (25°C) before heating to >37°C (100°C).
[0057] Figure 6 B shows the Figure 5 SEM image, particle size distribution, and hydrodynamic particle size distribution determined by DLS of the same mixture in A after heating to >37°C (100°C) for 30 minutes and subsequent cooling to room temperature (25°C).
[0058] Figure 7 Shown are the average UV-Vis spectra of single polymer 13 and single polymer 14 (line type: ----), the average UV-Vis spectrum of a mixture of polymer 13 and polymer 14 at room temperature (25°C) before heating to >37°C (100°C) (line type: ———), and the average UV-Vis spectrum of a mixture of polymer 13 and polymer 14 after heating to >37°C (100°C) for 30 minutes and subsequently cooling to room temperature (25°C) (line type: ———).
[0059] Figure 8 Another possible reaction scheme for RAFT polymerization is shown for producing the first polymer or the second polymer of the mixture according to the invention.
[0060] Fig. 9 Schematically shown is the self-assembly of a branched first polymer and a branched second polymer, which may comprise a mixture according to the invention.
[0061] Example 1 - Basic principles of polymer assembly in mixtures
[0062] Israelachvili et al. proposed their amphiphilic molecular self-organization theory in 1976 and introduced the critical arrangement parameter (P c ) was used to predict the supramolecular structure formation of amphiphiles (Israelachvili, JN et al., Theory of selfassembly of hydrocarbon amphiphiles into micelles and bilayers., Journal of the Chemical Society-Faraday Transactions, 72: 1525-1568 (1976)).
[0063] The critical arrangement parameter is defined as:
[0064] P c =v / a0l c
[0065] in
[0066] v: volume of the hydrophobic part,
[0067] a0: area occupied by the hydrophilic head group,
[0068] l c : The straight length of the molecule.
[0069] Therefore, the critical alignment parameter describes the molecular form associated with the curvature at the hydrophobic-hydrophilic interface, thus enabling the prediction of self-organized structures.
[0070] P c Values below 0.5 (especially ≤ 0.33) lead to the formation of highly curved aggregates such as spherical and cylindrical micelles (monolayer arrangement). c Values between 0.5 and 1 result in the formation of vesicles (bilayer arrangement). c Values > 1 result in the formation of reverse micelles.
[0071] In the present case, the first polymer and the second polymer of the mixture according to the present invention do not have one hydrophilic region (part) and one hydrophobic region (part), but two hydrophilic regions (parts). Therefore, strictly speaking, the first polymer and the second polymer of the mixture according to the present invention are not amphiphilic molecules.
[0072] However, the self-assembly theory developed by Israelachvili et al. can also be applied to the first polymer and the second polymer of the mixture according to the present invention (see, for example, Polymer Vesicles, DE Discher & A. Eisenberg; Science, 297: 967-973). In the polymers of the mixture according to the present invention, the "hydrophobic" region in the amphiphilic molecule in the theory corresponds to the region of the first polymer and the second polymer containing monomers each covalently bound to a base. This region of the first polymer and the second polymer leads to the assembly of the first polymer and the second polymer in an aqueous medium at a temperature of ≤37°C by hybridization of complementary bases between the first polymer and the second polymer, thereby forming micelles or vesicles. This favorable interaction leads to microscopic phase separation of the non-functionalized hydrophilic part from other hydrophilic parts, which are assembled with their complementary parts by forming hydrogen bonds and π-stacking. As a result, the two polymer parts are not uniformly miscible, but phase separation is caused by segregation, which is the reason for the formation of supramolecular structure.
[0073] This type of assembly is similar to the assembly of lipid hydrophobic regions, which is driven by the hydrophobic effect. However, unlike the assembly of lipids by the hydrophobic effect, the assembly of polymers in the mixture according to the invention can be abolished by increasing the temperature to a temperature in the range of >37°C, which causes the assembled micelles or vesicles to disassemble, i.e. lose their micellar or vesicular structure.
[0074] Regions (parts) of the first polymer and the second polymer that do not have monomers that bind to bases (e.g., regions that include or consist of PEG) can be suitable for promoting phase separation. The advantage is that such regions (parts) are more hydrophilic than regions (parts) of the first polymer and the second polymer that include monomers that are attached to bases.
[0075] Since the self-assembly theory developed by Israelachvili et al. can also be applied to the first polymer and the second polymer of the mixture according to the present invention, the critical arrangement parameter of the first polymer and the second polymer of the mixture according to the present invention can be defined as:
[0076] P c =v / a0l c
[0077] in
[0078] v: the volume of the region in the polymer containing monomers each bound to a base (base-containing region),
[0079] a0: the area formed by the region of the polymer that does not have monomers that bind to bases (i.e., the base-free region),
[0080] l c : The straight length of the polymer molecule.
[0081] For the first polymer and the second polymer, P c should be substantially the same (preferably within a maximum of 10%). c Values below 0.5 (especially ≤ 0.33) will result in the first polymer and the second polymer assembling to form spherical and cylindrical micelles, while the common P c A value of 0.5 to 1 results in the first polymer and the second polymer assembling to form a vesicle. c A value > 1 may lead to assembly to form reverse micelles. c The value is between 0.5 and 1 because within this range vesicles are formed, which is a preferred embodiment of the present invention.
[0082] Example 2 - Linking of bases to monomers
[0083] As bases, protected nucleosides in the form of 2',3'-acetonide are used to position the 5' position. For reasons of stability, methacrylamide-functionalized ribonucleosides are preferably used instead of methacrylate derivatives which can be synthesized enzymatically. Cytidine-based (1) and guanosine-based (2) monomers (see Figure 2 B) was synthesized by a two-step process involving oxidation of the primary hydroxyl group and subsequent amide coupling using N-(3-aminopropyl)methacrylamide (see Figure 2 A) Despite the higher nucleophilicity of the exocyclic -NH2 group, unlike enzymatic esterification, no protection step is required for this functional group.
[0084] To oxidize commercially available 2',3'-isopropylidene-cytidine and 2',3'-isopropylidene-guanosine to their carboxylic acid derivatives, the acetal-protected ribonucleosides were briefly oxidized using TEMPO and BAIB in the presence of NaHCO3. After filtering the precipitate, oxidized cytidine (3) was obtained in 44% yield, while the yield of oxidized guanosine (4) was quantitative as a white powder (see Figure 1 A). In the presence of 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and N-methylmorpholine (NMM), compounds 3 and 4 (see Figure 2 A) and N-(3-aminopropyl)methacrylamide hydrochloride to obtain compounds 1 and 2 (see Figure 2 B), with yields of 44% and 52% respectively (see Figure 2 A). The chemical structure was confirmed by NMR spectroscopy and ESI-MS analysis.
[0085] Compound 2 has a lower solubility than compound 1, but both ribonucleoside methacrylamide-based monomers show sufficient solubility in nonpolar solvents such as chloroform and ether, polar solvents such as aprotic solvents such as dichloromethane, acetone and dimethylformamide, and protic solvents such as water, methanol and ethanol. This solubility behavior can be explained by the simultaneous formation of hydrogen bonds and hydrophobic parts in the molecule. Due to the high solubility of these two monomer molecules, no further deprotection of the nucleoside monomers was performed during the polymerization process.
[0086] Example 3 - Preparation of the base-containing portion of the polymer
[0087] RAFT-mediated polymerization is one of the most important and well-known polymerization techniques currently, involving free radical initiators and chain transfer agents (CTAs). Here, the dithioester-based CTA 4-cyano-4-(phenylthiocarboxymethylthio) valeric acid (CPADB) was chosen, as it has been described for the polymerization of methacrylamide-based monomers.
[0088] Compounds 1 and 2 (see Figure 2 B) Homopolymerization using RAFT polymerization with ACVA as thermal initiator at 75 °C. Polymerization of nucleoside-based monomers was performed with a [M0]:[CTA0]:[I0] ratio of 75:3:1. Solvent mixtures of 8:2 DMF / H2O and 9:1 1,4-dioxane / H2O were observed, and it was found that different nucleoside types produced different effects. The use of a 9:1 1,4-dioxane / H2O mixture resulted in a high conversion of the G-based polymer (piGPMA) (94%), while the conversion of the cytidine-based polymer (piCPMA) decreased to 34% using the same solvent mixture. On the other hand, in 8:2 DMF / H2O, the conversion of piCPMA increased to 40%, while the conversion of piGPMA decreased to only 70%.
[0089] The polymerization of nucleoside homopolymers and their monomer conversion were determined by comparing the typical C-4 proton integrals of piCPMA (δ 4.43 ppm) and piGPMA (δ 4.50 ppm) with the vinyl peak integrals of iCPMA (δ 5.64 ppm and 5.30 ppm) and iGPMA (δ 6.39 ppm and 5.61 ppm) monomers. The theoretical molecular weights (Mn, theoretical, NMR) are summarized in Figure 3 middle.
[0090] The acetonide protecting groups of the two ribonucleoside homopolymers were removed under acidic conditions with trifluoroacetic acid (see Figure 2 D) to improve the hydrophilicity which needs to be increased due to poor solubility.
[0091] Example 4 - Preparation of a polymer of a mixture according to the invention
[0092] The polymers according to the present invention, specifically block copolymers with nucleosides (pHPMA-b-piCPMA 11 and pHPMA-b-piGPMA 12), were prepared using RAFT-mediated polymerization technology.
[0093] Specifically, a base-free polymer was first prepared. Poly(N-(2-hydroxypropyl)methacrylamide) (pHPMA) was selected because it is biocompatible. To this end, the HPMA macroinitiator was first prepared by RAFT-mediated polymerization according to S. Perrier (50th Anniversary Perspective, RAFT Polymerization-A User Guide, Macromolecules, 2017, 50, 7433-7447). The conversion rate of the monomer to pHPMA was 75%, and the theoretical Mn obtained was 7.8 kDa.
[0094] Subsequently, compound 1 or compound 2 (see Figure 2 B) Polymerized with pHPMA to prepare polymers (block copolymers) according to the present invention. These polymers are synthesized with low "activity" rates. "Activity" is the property that allows the chain to be extended. It indicates how many "active" chains remain intact for further block copolymerization. Low "activity" leads to a large number of dead ends, resulting in base-based polymers without phenyl-containing Z groups, which may interfere with UV-Vis spectral analysis. The calculated "activity" rate remains low, at 36.0% for polymer 11 and 15.6% for polymer 12.
[0095] Polymerization of compound 1 or compound 2 was carried out in the most suitable solvent system for homopolymers: 8:2 DMF / H2O for compound 1 and 9:1 1,4-dioxane / H2O for compound 2. The purine-based compound 2 showed higher conversion than the pyrimidine-based compound 1, and thus higher molecular weight (see Figure 4 The monomer conversion was determined by comparing the integration of the monomer peak (1: δ 5.30 ppm; 2: δ 5.61 ppm) and the nucleoside-based polymer peak (b-piCPMA δ 4.37 ppm or b-piGPMA δ 6.14 ppm). The monomer conversion of polymer 11 was 68%, while that of polymer 12 was 78% (see Figure 4 ).
[0096] The two nucleoside-based block copolymers 11 and 12 exhibited low solubility in water due to the incorporated bases.
[0097] The block copolymer ( Figure 2 D). Successful deprotection was confirmed by the disappearance of two singlets from the acetal protecting groups in polymer 11 (δ 1.46 ppm and 1.28 ppm) and polymer 12 (δ 1.48 and 1.33 ppm) in 1H NMR spectroscopy. After a total of 2 hours of shaking, polymers 13 and 14 ( Figure 4 D), which is a polymer according to the invention and exhibits a higher solubility in water.
[0098] Example 5 - Assembly of polymers to form vesicles
[0099] SEM and DLS analysis were performed ( Figure 5 and Figure 6 ) to study the formation of vesicles due to hydrogen bonding interactions between purine and pyrimidine functional groups (see Figure 1 ).
[0100] SEM images showed that pHPMA-b-pCPMA 13 formed large network structures in aqueous solution. These structures were formed by stronger CC interactions and had a wide particle size distribution with an average particle size of 280 nm. This wide particle size distribution was also determined by DLS with a polydispersity index (PDI) of 0.421. The average hydrodynamic diameter of polymer 13 was 507 nm. However, the SEM image of pHPMA-b-pGPMA 14 showed small particles due to GG interactions with an average particle size of 86 nm. According to DLS, its particle size distribution was smaller with an average hydrodynamic diameter of approximately 144 nm (PDI = 0.213) ( Figure 5 ).
[0101] After mixing the two complementary block copolymers, particles with an average hydrodynamic diameter of about 165 nm and a PDI of 0.3 were obtained. Heating the mixture to 100 °C for 30 minutes followed by cooling resulted in a narrower particle size distribution with a smaller average particle size of 266 nm and a hydrodynamic diameter of 136 nm ( Figure 6 ).
[0102] This observation can be explained by the breaking of strong CC and GG hydrogen bonds at higher temperatures and the restoration of CG interactions upon cooling to room temperature (rt). Ultrasonic treatment of polymers 13, 14 and the mixture of both polymers 13, 14 did not induce any morphological changes, indicating a high degree of stability.
[0103] The bases exhibit strong UV absorption due to hydrogen bonding and π-π interactions. The base pairing interactions of the base derivatives lead to changes in the UV-Vis spectra. Spectrophotometric measurements were performed to investigate the hydrogen bonding interactions of the complementary nucleoside-containing polymers 13 and 14 ( Figure 7 ).
[0104] The UV absorption spectra of the individual polymers 13 and 14 were compared with the spectra of the heated mixtures. The average values of the individual polymers pHPMA-b-pCPMA 13 and pHPMA-b-pGPMA 14 were similar to the absorbance of the mixture of the two polymers at the same concentration, which is due to the hydrogen bonding in the individual polymers.
[0105] Upon heating the polymer mixture to a temperature >37°C (100°C) for 30 min, a decrease in absorbance (hypochromism) was observed, which was due to the reassembly of complementary CG interactions upon heating and cooling.
[0106] Hypochromic effects at 260 nm are considered to be the hallmark of dsDNA-like structures, which have lower absorption than ssDNA, indicating that polymers 13 and 14 successfully assembled into vesicles through their base hybridization.
[0107] Example 6 - Alternative preparation of polymers of mixtures according to the invention
[0108] In Example 4, a first example is given of how a polymer according to the invention, i.e. a polymer of the mixture according to the invention, can be prepared. An alternative manufacturing process is described below, which is also based on RAFT-mediated polymerization (see Figure 8 ).
[0109] Monomers of (N-(2-hydroxypropyl)methacrylamide (HPMA) are linked to a homopolymer, each monomer of which contains an active ester group, thereby forming a block copolymer. The first block of the block copolymer is formed by a homopolymer, each monomer of which contains an active ester group, and the second block is formed by poly-(N-(2-hydroxypropyl)methacrylamide (pHPMA). If this block copolymer is now coupled with a base and deprotected, the base being bound to a hydrophilic spacer group carrying an amino group, the active ester groups of the monomers of the first block copolymer react with the amino groups of the spacer group bound to the base, so that each base is bound to the monomers of the first block of the block copolymer via its hydrophilic spacer group and via an amide bond. The result is a block copolymer in which the first block consists of monomers to which the base is each bound (via a hydrophilic linking group) and the second block consists of pHPMA.
[0110] Example 7 - Assembly of branched polymers
[0111] Both the first polymer and the second polymer can be branched polymers, ie, polymers having at least three arms (eg, 3-arm PEG or 4-arm PEG).
[0112] In this case, it is advantageous if the first polymer and the second polymer comprise at least six bases, each of which is covalently bound to a monomer of the polymer, and these bases are distributed at the first end and the second end of the first polymer and the second polymer, respectively. For example, the first polymer comprises six monomers at the first end, each of which is covalently bound to a base, and six monomers at the second end, each of which is covalently bound to a base (see Fig. 9 : oligomeric block 1), the second polymer comprises six monomers each covalently bonded to a base at the first end and six monomers each covalently bonded to a base at the second end (see Fig. 9 : complementary oligomeric blocks 2).
[0113] Branching in the first polymer and the second polymer can be achieved by combining the monomers of the first polymer and the monomers of the second polymer with an additional polymer (e.g. PEG), which is not (directly) attached to the base and is located between the first end and the second end of the first polymer and the second polymer, respectively (especially in the middle), optionally through a spacer group (or a linker group, such as a linker group of the polymer). In this case, this additional polymer branches out from the first polymer and the second polymer, so that the first polymer and the second polymer form a "fork-like structure" (see Fig. 9 ). In an aqueous phase at a temperature ≤ 37°C, when the first polymer is combined with the second polymer, the additional polymer advantageously causes phase separation (see Fig. 9 : polymer block for phase separation).
[0114] If the mixture according to the invention comprises two branched polymers, it is advantageous for the assembly to form micelles or vesicles if the volume fraction of the regions of the first and second polymers that assemble in aqueous solution (i.e. the regions comprising monomers that are each bound to a base) is as close as possible to the volume fraction of the regions of the first and second polymers that do not assemble in aqueous solution (i.e. the regions comprising monomers that are not bound to a base in each case).
[0115] The first polymer and the second polymer may each comprise a 4-arm PEG (e.g. having a molar mass of 5000 g / mol), wherein at least two arms of the 4-arm PEG comprise monomers (preferably at the ends of the arms) which are in each case covalently bound to a base. These monomers may represent an oligomer consisting of monomers which are consecutively bound to a base (e.g. each arm has four or six such monomers). The oligomer may be in the form of an oligonucleotide.
Claims
1. A mixture comprising a) a first polymer comprising at least six bases, each of which is covalently bonded to a monomer of the polymer; and b) a second polymer comprising at least six bases, each of which is covalently bound to one monomer of the polymer, wherein the at least six bases of the second polymer are complementary to the at least six bases of the first polymer; Features The first polymer and the second polymer can react in aqueous solution through their complementary bases. At temperatures ≤37°C, they assemble into micelles or vesicles by forming hydrogen bonds between their complementary bases, and At temperatures >37°C, they do not assemble into micelles or vesicles due to the lack of hydrogen bonding between their complementary bases.
2. The mixture according to the preceding claim, characterized in that The mixture further comprises an active substance, wherein the active substance is preferably selected from the group consisting of pharmaceutically active substances, cosmetic substances, sensor substances, lubricants, coolants, adhesives and combinations thereof, wherein the active substance is particularly preferably selected from the group consisting of pharmaceutically active substances, fragrances, antiperspirants, UV protective substances, coolants, lubricants, adhesives and combinations thereof.
3. A mixture according to any one of the preceding claims, characterised in that i) the first polymer comprises or consists of at least 20 monomers, preferably at least 50 monomers, particularly preferably at least 100 monomers, very particularly preferably at least 200 monomers, in particular at least 500 monomers; and / or ii) The second polymer comprises or consists of at least 20 monomers, preferably at least 50 monomers, particularly preferably at least 100 monomers, very particularly preferably at least 200 monomers, in particular at least 500 monomers.
4. A mixture according to any one of the preceding claims, characterised in that i) the first polymer comprises at least ten bases, preferably at least twelve bases, particularly preferably at least 14 bases, in particular at least 16 bases, optionally at most 18 bases, each of which is covalently bonded to a monomer of the first polymer; and ii) the second polymer comprises at least ten bases, preferably at least twelve bases, particularly preferably at least 14 bases, in particular at least 16 bases, optionally at most 18 bases, each of which is covalently bonded to a monomer of the second polymer, wherein the bases of the second polymer are complementary to the bases of the first polymer.
5. A mixture according to any one of the preceding claims, characterised in that i) in the first polymer, between two consecutive monomers each bound to a base, at most three monomers, preferably at most two monomers, particularly preferably at most one monomer, which are not covalently bound to a base are arranged, in particular no monomers which are not covalently bound to a base are arranged; and / or ii) In the second polymer, between two consecutive monomers each bound to a base, a maximum of three monomers, preferably a maximum of two monomers, particularly preferably a maximum of one monomer, are arranged which are not covalently bound to a base, in particular no monomers which are not covalently bound to a base are arranged.
6. A mixture according to any one of the preceding claims, characterised in that i) the bases in the first polymer are bases comprising or consisting of cytosine, isocytosine and / or adenine, preferably cytosine; and / or ii) The base in the second polymer is a base comprising or consisting of guanine, isoguanine and / or thymine, preferably guanine.
7. A mixture according to any one of the preceding claims, characterised in that i) the base of the first polymer is bound to the monomer of the first polymer via a ribose residue, wherein the base is preferably bound to the C1 atom of the ribose residue and the monomer is bound to the C5 atom of the ribose residue; ii) The base of the second polymer is bound to each monomer of the first polymer via a ribose residue, wherein the base is preferably bound to the C1 atom of the ribose residue and the monomer is bound to the C5 atom of the ribose residue.
8. A mixture according to any one of the preceding claims, characterised in that monomers of the first polymer and / or the second polymer, each of which is bound to a base, i) each comprises or consists of a residue selected from the group consisting of an amino acid residue, a sugar residue, a ribose phosphorylation residue, a methacrylamide residue and a combination thereof, wherein the residue is preferably selected from the group consisting of a ribose phosphorylation residue, a methacrylamide residue and a combination thereof, wherein the residue is particularly preferably selected from the group consisting of a ribose-5-phosphate residue, an N-(3-aminopropyl)-methacrylamide residue and a combination thereof; and / or ii) forming a homopolymer, wherein the homopolymer is preferably selected from the group consisting of polypeptides, polysaccharides, polyribose phosphate, polymethacrylamide and combinations thereof, wherein the homopolymer is particularly preferably selected from the group consisting of poly-ribose phosphate, polymethacrylamide and combinations thereof, wherein the homopolymer is particularly selected from the group consisting of poly-ribose-5-phosphate, poly-(N-(3-aminopropyl)-methacrylamide and combinations thereof; and / or iii) covalently bonded to the base via a bond selected from an ester bond, a thioester bond, an ether bond and an amide bond, optionally via a ribose residue, wherein the bond is preferably an amide bond, particularly preferably an amide bond to a ribose residue, the ribose residue being covalently bonded to the base, in particular an amide bond to the C5 atom of the ribose residue, the ribose residue being covalently bonded to the base at its C1 atom.
9. A mixture according to any one of the preceding claims, characterised in that monomers of the first polymer and / or the second polymer, each of which is not bound to a base, i) each comprises or consists of a residue selected from the group consisting of (N-(2-hydroxypropyl)methacrylamide residues, vinylamine residues, butadiene residues, ethylene oxide residues, acrylic acid residues, amino acid residues, sugar residues and combinations thereof; and / or ii) forming a homopolymer, a block copolymer or a heteropolymer, wherein the homopolymer is preferably selected from poly-(N-(2-hydroxypropyl)methacrylamide, polyvinylamine, polyethylene oxide, polypeptides, polysaccharides and combinations thereof, particularly preferably poly-(N-(2-hydroxypropyl)methacrylamide, and / or the block copolymer is preferably selected from polybutadiene-polyethylene oxide, polyvinylamine-polyethylene oxide, polyglutamic acid-polyethylene oxide, polyacrylic acid and combinations thereof, and / or the heteropolymer is preferably selected from polypeptides, polysaccharides and combinations thereof.
10. A mixture according to any one of the preceding claims, characterised in that The mixture contains no organic solvent.
11. The mixture according to any of the preceding claims for use in medicine, preferably for the thermal release of active substances, particularly preferably for the thermal release of active substances for the treatment of cancer.
12. An aqueous solution comprising a mixture according to any one of the preceding claims, wherein the first polymer and the second polymer are at least partially assembled into micelles or vesicles.
13. The aqueous solution according to claim 12, characterized in that The micelles and / or vesicles have a mean hydrodynamic radius of 30 nm to 300 nm, preferably 50 nm to 200 nm, optionally 100 nm to 150 nm, as determined by dynamic light scattering.
14. The aqueous solution according to any one of claims 12 or 13, characterized in that The micelles and / or vesicles contain active substances in the inner space, wherein the active substances are preferably selected from pharmaceutical active substances, cosmetic substances, sensor substances, lubricants, coolants, adhesives and combinations thereof, wherein the active ingredients are particularly preferably selected from pharmaceutical active substances, fragrances, antiperspirants, UV protective substances, coolants, lubricants, adhesives and combinations thereof.
15. Use of an aqueous solution according to any one of claims 12 to 14 for the thermal release of active substances, preferably for the release of active substances selected from the group consisting of pharmaceutical active substances, cosmetic substances, sensor substances, lubricants, coolants, adhesives and combinations thereof, wherein the active ingredient is particularly preferably selected from the group consisting of pharmaceutical active substances, fragrances, antiperspirants, UV protection substances, coolants, lubricants, adhesives and combinations thereof.
